[1] World Health Organization. In de Benoist B, Mclean E,et al. Worldwide prevalence of anaemia 1993-2005. WHO Global Database on Anaemia. Geneva: World Health Organization, 2008 (NLM: WH 155). [2] 靳蕾,叶荣伟,王荣琴,等.妇女孕前贫血与孕期贫血间关系的研究[J].中华流行病学杂志,2010,31(1):114. [3] 中国儿童、孕妇、育龄妇女铁缺乏症流行病学调查协作组.中国孕妇、育龄妇女铁缺乏症患病率调查[J].中华血液学杂志,2004,25:653-657. [4] Reveiz L, Gyte GM, Cuervo LG, et al. Treatments for iron-deficiency anaemia in pregnancy[J]. Cochrane Database Syst Rev,2012,1:CD003094. [5] Breymann C,Bian XM,Blanco-Capito LR,et al.Expert recommendations for the diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific region[J].J Perinat Med,2011,39(2):113-121. [6] Auerbach M,Ballard H.Clinical use of intravenous iron: administration, efficacy, and safety [J].Hematology Am Soc Hematol Educ Program,2010:338-347. [7] 中华医学会妇产科学分会,漆洪波,常青,等.孕前和孕期保健指南[J].中华妇产科杂志,2011,46(2):150-153. [8] World Health Organization. In Vir SC & Cavalli-Sforza T (eds.). Weekly iron folic acid supplementation (WIFS) program for women of reproductive age (WRA): an analysis of best program practices. Geneva: World Health Organization, 2011. [9] World Health Organization. Iron deficiency anaemia assessment prevention and control: a guide for programme managers. Geneva: World Health Organization, 2001. 132 (WHO/ NHD/01.3). [10] Pena- Rosas JP & Viteri FE. Effects and safety of preventive oral iron or iron + folic acid supplementation for women during pregnancy. Cochrane Database Syst Rev 2009. Issue 4. Art.No: CD004736. DOI: 10.1002/ 14651858. CD004736 pub 3. [11] Molloy AM, Kirke PN, Troendle JF,et al. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification[J]. Pediatrics ,2009,123(3): 917-923. |